pipette
ESEspañol

T cell–mediated depletion of intratumoral regulatory T cells using a CCR8xCD3 T cell–engaging bispecific antibody (TCB) promotes antitumor immunity in preclinical mouse models

Baomei Wang, Isabel E. Ishizuka, Emel Esen, Ji Li, Cecilia Chiu, Yonglian Sun, Zhonghua Lin, Dhaya Seshasayee, Aija Kusi, Yu Zhong, Wendy Halpern, Adeyemi O. Adedeji, Lanlan Yu, Peter Tran, Zhaojun Yin, Shang‐Fan Yu, Geoff Del Rosario, Yoko A. Oei, Yagai Yang, Jill M. Schartner, Mary Ann Go, Giulia Protti, Sören Müller, Cong Wu, Ran Li, Genee Lee, James T. Koerber, Sascha Rutz, Teemu T. Junttila

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Here, we have developed a CCR8xCD3 TCB and show that it effectively depletes CCR8-expressing T reg cells in a T cell–mediated manner.

Appeared: Friday, October 30. Science Translational Medicine. Peer-reviewed journal.

DOI: 10.1126/scitranslmed.aea7127